Device Trial Radar · NCT01812174
On-X Heart Valve - 17mm Aortic and 23mm Mitral
Last checked: Nov 20, 2026Latest source record: Mar 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
20
Actual
Start
Nov 18, 2011
Primary completion
Dec 7, 2018
Study completion Dec 7, 2018
Sponsor
- Lead sponsor
- On-X Life Technologies, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 18, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study examines the hemodynamic and hemolytic properties of two additional smaller size valves to the On-X line of valves already approved by FDA.
Conditions
- Heart Valve Disease
Interventions
17mm aortic valve (On-X )Device
Heart aortic valve replacement surgery: 17mm Aortic
23mm mitral valve (On-X)Device
Heart mitral valve replacement surgery: 23mm Mitral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Valve Related Adverse Events at 1 YearTime frame: 1 Year
Locations
10 sites in 3 countries. Site status is shown where the registry gives one.
Arkansas Children's Hospital
Little Rock, Arkansas
Maine Medical Center
Portland, Maine
Children's Heart Center Nevada
Las Vegas, Nevada
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.